FTSE 100 news / Companies and sectors / Haleon / 15 October 2026

Haleon (HLN): news on Thursday 15 October 2026

+5.5 positive

Coverage was mildly positive, with commentary on Sensodyne helping the latest results and a valuation piece calling the shares undervalued on cash flow. A smaller story on an Excedrin marketing game added a little to the brand-strength angle.

What drove it

Sensodyne-led results
undervaluation view
Excedrin brand marketing

The 3 stories

Each headline's own score, strongest first. Links go to the publisher.

+7.0 Haleon (LSE:HLN) Stock May Be 43% Undervalued On Cash Flow Simply Wall Street
Valuation analysis suggests shares significantly undervalued on cash flow.
+6.3 How Is Haleon (LSE:HLN) Stock Reacting After Sensodyne Powers Its Latest Results? Kalkine Media
Sensodyne credited with powering latest results; share reaction discussed.
+3.0 Is Haleon (LSE:HLN) Using Excedrin’s Nostalgic Game To Redefine Consumer Health Brand Moats? Yahoo Finance
Excedrin brand marketing campaign framed as strengthening brand moat.

Haleon: every day · Pharma and healthcare on 15 October 2026 · FTSE 100 overview for the day